FGF21 and obesity due to melanocortin 4 receptor deficiency: In recent years, FGF21 has gained attention as an important regulator of metabolic processes at the systemic level, with multiple beneficial effects in different pathologies such as diabetes, insulin resistance, and obesity, among others (42, 58, 59).